P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMICAL ANALYSIS

被引:0
|
作者
AMBROS, RA
ROSS, JS
KALLAKURY, BVS
MALFETANO, J
KIM, YR
HWANG, J
BREESE, K
FIGGE, J
机构
[1] ALBANY MED COLL,DEPT MICROBIOL,ALBANY,NY 12208
[2] ALBANY MED COLL,DEPT IMMUNOL,ALBANY,NY 12208
[3] ALBANY MED COLL,DEPT MOLEC GENET,ALBANY,NY 12208
[4] ALBANY MED COLL,DEPT MED,ALBANY,NY 12208
[5] ALBANY MED COLL,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,ALBANY,NY 12208
关键词
ENDOMETRIAL CARCINOMA; TUMOR-SUPPRESSOR GENES; P53; GENE; IMAGE ANALYSIS; QUANTITATIVE IMMUNOHISTOCHEMISTRY;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although detection of p53 protein by immunohistochemical testing was originally thought to indicate p53 gene mutation, recent analyses of human malignancies have shown that high expression of p53 protein may occur without detectable gene mutation. Several explanations have been proposed for this phenomenon, including mutation out of ''hot spot'' regions, overexpression of wild-type protein, sampling error in molecular analyses, and conformational changes of wild-type p53 protein. As discussed, it is unlikely that the first two possibilities contribute significantly to the occurrence of this phenomenon, and the current study examined the possibility that sampling error in molecular analyses might account for a lack of concordance between immunohistochemical and molecular analyses. Such a possibility exists because immunohistochemical studies frequently report high expression when staining is only focal or regional and molecular analyses are based on the polymerase chain reaction, which is highly exponential in nature and may not detect mutation if the target gene segment is not amplified early in the chain reaction. In the current report, p53 protein expression was examined by immunohistochemical testing in 45 cases of endometrioid carcinoma, and all cases showing diffuse positivity were then examined by polymerase chain reaction in combination with single-strand conformational analysis for exons 4 to 9 with the use of a microdissection technique to separate malignant from benign cells. Of the 45 cases, diffuse staining was found in four cases, and only two of the four were found to show evidence of gene mutation. This study concluded that high p53 protein expression can occur without evidence of gene mutation in endometrial carcinoma; because all four cases examined by polymerase chain reaction with single-strand conformational analysis in this study showed diffuse staining by immunohistochemical analysis, it seems unlikely that sampling error in molecular analysis accounts for the lack of concordance. As discussed, it seems distinctly possible that conformational changes of the p53 wild-type protein account for this phenomenon. Further investigation into this possibility might be beneficial.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 50 条
  • [1] P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMISTRY (IMH)
    KALLAKURY, BVS
    AMBROS, RA
    ROSS, JS
    MALFETANO, JH
    KIM, Y
    HWANG, J
    FIGGE, J
    [J]. LABORATORY INVESTIGATION, 1995, 72 (01) : A91 - A91
  • [2] P53 protein as a predictor of survival in endometrial carcinomas
    Nordstrom, B
    Nilsson, S
    Strang, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1173 - 1173
  • [3] Immunohistochemical detection of p53 and p53 gene mutations in meningioma
    Hirato, J
    Sakurai, S
    Nakazato, Y
    [J]. BRAIN PATHOLOGY, 1997, 7 (04) : 1193 - 1193
  • [4] The computer search of targets, analysis of p53 gene and p53 protein
    Vishnyakova, AV
    Brit, IS
    Alekseenko, VV
    Odynets, KA
    Belov, YA
    Buchatskiy, LP
    Dyma, PK
    [J]. EXPERIMENTAL ONCOLOGY, 2002, 24 (03) : 237 - 238
  • [5] Expression of p53 protein in endometrial carcinomas: Relationship with ER and PR status
    Athanassiades, P
    Athanassiadou, P
    Petrakakou, E
    Karkabasi, A
    Kavatzas, N
    Demopoulos, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 48 - 48
  • [6] Infrequent p53 gene mutation but UV gradient-like p53 protein positivity in keloids
    Heitzer, Ellen
    Seidl, Hannes
    Bambach, Isabella
    Schmidbauer, Ulrike
    Cerroni, Lorenzo
    Wolf, Peter
    [J]. EXPERIMENTAL DERMATOLOGY, 2012, 21 (04) : 277 - 280
  • [7] IMMUNOHISTOCHEMICAL ANALYSIS OF P53 EXPRESSION IN HUMAN PANCREATIC CARCINOMAS
    ZHANG, SY
    RUGGERI, B
    AGARWAL, P
    SORLING, AF
    OBARA, T
    URA, H
    NAMIKI, M
    KLEINSZANTO, AJP
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1994, 118 (02) : 150 - 154
  • [8] Molecular and immunohistochemical analysis of p53 mutations in breast carcinomas
    Zachariou, Christianna
    Malamou-Mitsi, Vassiliki
    Skyrlas, Angelos
    Agnantis, Niki
    [J]. VIRCHOWS ARCHIV, 2007, 451 (02) : 567 - 567
  • [9] Immunohistochemical analysis of p53 expression in primary breast carcinomas
    Naidu, R
    Yadav, M
    Nair, S
    Kutty, KK
    [J]. ANTICANCER RESEARCH, 1998, 18 (1A) : 65 - 70
  • [10] Stratification of endometrial endometrioid carcinoma with a support of p53 immunohistochemical status
    Yano, Mitsutake
    Ito, Kozue
    Yabuno, Akira
    Katoh, Tomomi
    Ogane, Naoki
    Miyazawa, Mariko
    Miyazawa, Masaki
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    [J]. LABORATORY INVESTIGATION, 2019, 99